David B. Ring

Person

Redwood City, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of glycogen synthase kinase 3
- Patent number 7,425,557
- Issue date Sep 16, 2008
- Novartis Vaccines and Diagnostics, Inc.
- John M Nuss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Biosynthetic binding proteins for immuno-targeting
- Patent number 7,138,497
- Issue date Nov 21, 2006
- Chiron Corporation
- Lou L. Houston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of glycogen synthase 3 kinase
- Patent number 7,053,097
- Issue date May 30, 2006
- Chiron Corporation
- Peter Schultz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of glycogen synthase kinase 3
- Patent number 7,045,519
- Issue date May 16, 2006
- Chiron Corporation
- John M. Nuss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of glycogen synthase kinase 3
- Patent number 7,037,918
- Issue date May 2, 2006
- Chiron Corporation
- John M. Nuss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of glycogen synthase kinase 3
- Patent number 6,489,344
- Issue date Dec 3, 2002
- Chiron Corporation
- John M. Nuss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized antibody and uses thereof
- Patent number 6,479,284
- Issue date Nov 12, 2002
- Dana-Farber Cancer Institute, Inc.
- Wayne A. Marasco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of glycogen synthase kinase 3
- Patent number 6,417,185
- Issue date Jul 9, 2002
- Chiron Corporation
- Dane A. Goff
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of glycogen synthase 3 kinase
- Patent number 6,153,618
- Issue date Nov 28, 2000
- Chiron Corporation
- Peter Schultz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal anti-multiple drug resistance antibody, methods of produ...
- Patent number 6,143,873
- Issue date Nov 7, 2000
- Chiron Corporation
- David Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibodies, methods of production and use thereof
- Patent number 6,106,833
- Issue date Aug 22, 2000
- Chiron Corporation
- David Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Identification and use of selective inhibitors of glycogen synthase...
- Patent number 6,057,286
- Issue date May 2, 2000
- Chiron Corporation
- Stephen D. Harrison
- G01 - MEASURING TESTING
Information Patent Grant
Identification and use of selective inhibitors of glycogen synthase...
- Patent number 6,057,117
- Issue date May 2, 2000
- Chiron Corporation
- Stephen D. Harrison
- G01 - MEASURING TESTING
Information Patent Grant
Antigen-binding sites of antibody molecules specific for cancer ant...
- Patent number 6,054,561
- Issue date Apr 25, 2000
- Chiron Corporation
- David B. Ring
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibodies, methods of production and uses thereof
- Patent number 5,959,084
- Issue date Sep 28, 1999
- Chiron Corporation
- David Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding antigen-binding sites specific for cancer an...
- Patent number 5,948,647
- Issue date Sep 7, 1999
- Chiron Corporation
- David B. Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding biosynthetic binding protein for cancer marker
- Patent number 5,877,305
- Issue date Mar 2, 1999
- Chiron Corporation
- James S. Huston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antigen-binding sites of antibody molecules specific for cancer ant...
- Patent number 5,849,877
- Issue date Dec 15, 1998
- Chiron Corporation
- David B. Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biosynthetic binding proteins for immuno-targeting
- Patent number 5,837,846
- Issue date Nov 17, 1998
- Creative Biomolecules, Inc.
- James S. Huston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated nucleic acid molecules encoding antigen binding sites of a...
- Patent number 5,811,267
- Issue date Sep 22, 1998
- Chiron Corporation
- David B. Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biosynthetic binding proteins for immunotargeting
- Patent number 5,753,204
- Issue date May 19, 1998
- Chiron Corporation
- James S. Huston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of CSF-1 to treat tumor burden
- Patent number 5,725,850
- Issue date Mar 10, 1998
- Chiron Corporation
- Peter Ralph
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of producing antigen forks
- Patent number 5,705,614
- Issue date Jan 6, 1998
- Chiron Corporation
- David B. Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal anti-human breast cancer antibodies
- Patent number 5,629,197
- Issue date May 13, 1997
- Cetus Oncology Corporation
- David B. Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biosynthetic binding proteins for immuno-targeting
- Patent number 5,534,254
- Issue date Jul 9, 1996
- Chiron Corporation
- James S. Huston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal anti-human breast cancer antibodies
- Patent number 5,169,774
- Issue date Dec 8, 1992
- Cetus Oncology Corporation
- Arthur E. Frankel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-human ovarian cancer immunotoxins and methods of use thereof
- Patent number 4,958,009
- Issue date Sep 18, 1990
- Cetus Corporation
- Michael J. Bjorn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-human ovarian cancer immunotoxins and methods of use thereof
- Patent number 4,956,453
- Issue date Sep 11, 1990
- Cetus Corporation
- Michael J. Bjorn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for imaging breast tumors using labeled monoclonal anti-huma...
- Patent number 4,938,948
- Issue date Jul 3, 1990
- Cetus Corporation
- David B. Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Assay for human breast cancer
- Patent number 4,803,169
- Issue date Feb 7, 1989
- Cetus Corporation
- Peter S. Linsley
- G01 - MEASURING TESTING

Patents Applicationslast 30 patents

Information Patent Application
Biosynthetic binding proteins for immuno-targeting
- Publication number 20070031931
- Publication date Feb 8, 2007
- Chiron Corporation
- L. L. Houston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of promoting an immune response with a bispecific antibody
- Publication number 20060177454
- Publication date Aug 10, 2006
- David B. Ring
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Biosynthetic binding proteins for immuno-targeting
- Publication number 20060147444
- Publication date Jul 6, 2006
- James S. Huston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitors of glycogen synthase kinase 3
- Publication number 20060089369
- Publication date Apr 27, 2006
- Chiron Corporation
- John M. Nuss
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of glycogen synthase kinase 3
- Publication number 20030130289
- Publication date Jul 10, 2003
- Chiron Corporation
- John M. Nuss
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD OF PROMOTING AN IMMUNE RESPONSE WITH A BISPECIFIC ANTIBODY
- Publication number 20030086922
- Publication date May 8, 2003
- DAVID B. RING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Biosynthetic binding proteins for immuno-targeting
- Publication number 20020168375
- Publication date Nov 14, 2002
- Chiron Corporation
- James S. Huston
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of glycogen synthase kinase 3
- Publication number 20020156087
- Publication date Oct 24, 2002
- John M. Nuss
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods for treating tumors
- Publication number 20020041865
- Publication date Apr 11, 2002
- Richard Austin
- C07 - ORGANIC CHEMISTRY

David B. Ring

Person

Patents Grantslast 30 patents

Inhibitors of glycogen synthase kinase 3

Biosynthetic binding proteins for immuno-targeting

Inhibitors of glycogen synthase 3 kinase

Inhibitors of glycogen synthase kinase 3

Inhibitors of glycogen synthase kinase 3

Inhibitors of glycogen synthase kinase 3

Humanized antibody and uses thereof

Inhibitors of glycogen synthase kinase 3

Inhibitors of glycogen synthase 3 kinase

Monoclonal anti-multiple drug resistance antibody, methods of produ...

Bispecific antibodies, methods of production and use thereof

Identification and use of selective inhibitors of glycogen synthase...

Identification and use of selective inhibitors of glycogen synthase...

Antigen-binding sites of antibody molecules specific for cancer ant...

Bispecific antibodies, methods of production and uses thereof

Nucleic acids encoding antigen-binding sites specific for cancer an...

DNA encoding biosynthetic binding protein for cancer marker

Antigen-binding sites of antibody molecules specific for cancer ant...

Biosynthetic binding proteins for immuno-targeting

Isolated nucleic acid molecules encoding antigen binding sites of a...

Biosynthetic binding proteins for immunotargeting

Use of CSF-1 to treat tumor burden

Methods of producing antigen forks

Monoclonal anti-human breast cancer antibodies

Biosynthetic binding proteins for immuno-targeting

Monoclonal anti-human breast cancer antibodies

Anti-human ovarian cancer immunotoxins and methods of use thereof

Anti-human ovarian cancer immunotoxins and methods of use thereof

Method for imaging breast tumors using labeled monoclonal anti-huma...

Assay for human breast cancer

Patents Applicationslast 30 patents

Biosynthetic binding proteins for immuno-targeting

Method of promoting an immune response with a bispecific antibody

Biosynthetic binding proteins for immuno-targeting

Inhibitors of glycogen synthase kinase 3

Inhibitors of glycogen synthase kinase 3

METHOD OF PROMOTING AN IMMUNE RESPONSE WITH A BISPECIFIC ANTIBODY

Biosynthetic binding proteins for immuno-targeting

Inhibitors of glycogen synthase kinase 3

Methods for treating tumors